FDA Investigator Kim M Downing
Kim M Downing has conducted inspections on 123 sites in 7 countries as of 11 Jul 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
123
Last Inspection Date:
11 Jul 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
United Kingdom of Great Britain and Northern Ireland,
China,
France,
Canada,
Belgium,
Ireland
FDA Investigators that have inspected at least one site in common with Kim M Downing:
Akbar J Zaidi,
Alice S Tsao,
Althea A Williams,
Amanda T Zick,
Amy S Graf,
Andrea A Branche,
Andrew B Paglia, DPM,
Andrew J Garufi,
Ann B Okon,
Arie C Menachem,
Benton M Ketron,
Bijoy Panicker,
Bill Tacket, Jr,
Brian J Ryan,
Brian M Campbell,
Carolyn J Cook,
CDR Sean T Creighton,
Charanjeet Jassal,
Cynthia Jim, CSO,
Daniel L Aisen,
David A Carlson,
David A Laplante,
David H Smith,
David R Delucia,
David R Lattuca,
Dipesh K Shah,
Dolores Harper,
Donald G Gordon,
Dr. Robert C Horan, MD,
Elizabeth H Davis,
Elizabeth H Slazak,
Ellen J Tave,
Eric S Pittman,
Erika E Englund, PhD,
Erin L Mcfiren,
Erin L Nagel,
Evelyn Taha,
Felix Maldonado,
George C Amedro,
Georgia A Layloff,
Gregory E Beichner,
Gregson A Joseph,
Harry J Brewer,
Helen B Ricalde,
Hilary K Wagner,
Iram R Hassan, PhD,
James A Beaulieu,
James D Bridges,
James D Planchon,
James M Odonnell,
Jazmine N Brown,
Jeanette L Mcginnis,
Joanne M Schlossin,
Joel R Merriman,
John A Podsadowski,
Johnna L Bleem,
Joseph J Vannelli,
Joseph Maselli,
Joshua J Silvestri,
Joy P Matthias,
Juan A Morales,
Jude C Dikes,
Judy Keihl,
Julie Scoma,
Karen L Kosar,
Kazi Rafiquzzaman,
Kenneth G Klobus,
Kevin A Gonzalez,
Kimberley A Ricketts,
Kimberly Lewandowski Walker,
Kirk A Dymbrowski,
Kyle J Spencer,
L Gnnmassimia Massimilla, PharmD,
Lauren E Blaser,
Leo J Lagrotte,
Linda M Sacco,
Marc S Neubauer,
Marcellinus D Dordunoo,
Marlene L Davis,
Mary M Finn,
Matthew D Schnittker,
Melanie G Warzala,
Melanie W Pishnery,
Melina Lrodriguez Upton,
Michael A Charles,
Michael P Sweeney,
Michael W Burd,
Michelle J Glembin,
Mindy M Chou,
Nicholas C Mendiola,
Parul M Patel,
Patrick C Klotzbuecher,
Paul E Stein,
Paul Mouris,
Peter Abel,
Rajiv R Srivastava,
Ralph Jerndal,
Richard K Glabach,
Richard L Rutherford,
Robert C Steyert,
Roy Baby,
Russ E Davis,
Salvatore N Randazzo,
Sarah A Hassas,
Sargum C Morgan,
Sargum C Sood,
Sayyem H Akbar,
Shafiq S Ahadi,
Shreya Shah,
Simone E Pitts,
Sony Mathews,
Stanley B Eugene, BS, BME,
Stephanie T Durso,
Stephen C Smith,
Steven R Ziser,
Suyang Qin,
Syeda N Mahazabin,
Tamara S Rosbury,
Tania E Vizcaino,
Tara K Carmody,
Tara K Normandin,
Thai T Duong,
Thomas P Hansen,
Victor Spanioli,
Wendy G Tan, PhD,
Wendy M Stone,
William C Corley,
William C Lubas,
William J Leonard
Kim M Downing's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more